about
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, inclu...
Read More
65.06
1.27
(1.99%)
480.8K
XNAS Volume
XNAS 13 Mar, 2026 3:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
AnaptysBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..